12.20 (0.75%) Sun Pharmaceutical Industries has informed that it has enclosed a Press Release on 10th May 2021 titled ‘Sun Pharma signing a voluntary licensing agreement with Eli Lilly for expanding access to Baricitinib to help alleviate the burden of Covid-19 in India’, which the company shall be releasing after sending this letter.
The above information is a part of company’s filings submitted to BSE.